L
Liselotte Onelöv
Researcher at Karolinska University Hospital
Publications - 12
Citations - 1017
Liselotte Onelöv is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Pulmonary embolism & Incidence (epidemiology). The author has an hindex of 7, co-authored 12 publications receiving 939 citations. Previous affiliations of Liselotte Onelöv include Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer
Lalle Hammarstedt,David Lindquist,Hanna Dahlstrand,Mircea Romanitan,Liselotte Onelöv,Jeanna Joneberg,Nomi Creson,Johan Lindholm,Weimin Ye,Tina Dalianis,Eva Munck-Wikland +10 more
TL;DR: A highly significant and parallel increase both in the incidence of tonsillar cancer and the proportion of HPV‐positive tumors is demonstrated, which should definitely influence future preventive strategies as well as treatment for this type of cancer.
Journal ArticleDOI
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7
David Lindquist,Mircea Romanitan,Lalle Hammarstedt,Anders Näsman,Hanna Dahlstrand,Johan Lindholm,Liselotte Onelöv,Torbjörn Ramqvist,Weimin Ye,Eva Munck-Wikland,Tina Dalianis +10 more
TL;DR: The presence of HPV‐16, but not viral load, in tonsillar cancer was shown to be a favourable prognostic factor for clinical outcome, and E6 and/or E7 were expressed in almost all assessable HPV‐ 16 positive cases, supporting an oncogenic role of HPV•16 in tonsilar cancer.
Journal ArticleDOI
The incidence of tonsillar cancer in Sweden is increasing
Lalle Hammarstedt,Hanna Dahlstrand,David Lindquist,Liselotte Onelöv,Michael Ryott,Juhua Luo,Tina Dalianis,Weimin Ye,Eva Munck-Wikland +8 more
TL;DR: The incidence of tonsillar cancer in Sweden is increasing, particularly among men, and risk factors other than smoking may have contributed to the observed secular trend in men, while in women, smoking can be a part of the explanation.
Journal ArticleDOI
Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma
Jovan P. Antovic,Mika Skeppholm,Jaak Eintrei,Elisabet Eriksson Boija,Lisbeth Söderblom,Eva-Marie Norberg,Liselotte Onelöv,Yuko Rönquist-Nii,Anton Pohanka,Olof Beck,Paul Hjemdahl,Rickard E. Malmström +11 more
TL;DR: LC-MS/MS is the gold standard for measurements of dabigatran in plasma, and either HTI or ECA assays may be used, but neither of these assays is dependable when monitoring low levels or to infer total absence of dabIGatran.
Journal ArticleDOI
Age‐adjusted D‐dimer cut‐off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays
Maria Farm,Maria Farm,Anwar J. Siddiqui,Liselotte Onelöv,I Järnberg,Jaak Eintrei,F Maskovic,Anders Kallner,Anders Kallner,Margareta Holmström,Margareta Holmström,Jovan P. Antovic,Jovan P. Antovic +12 more
TL;DR: Age‐adjusted D‐dimer cut‐off resulted in improved specificity with maintained sensitivity for all assays, and there was a substantial decrease in false positive results, especially in the older population.